The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
double bottom, up we go now
you will be alright, look at all the huge buys at 25p, must be institutions. I bought more also
21-Sep-21 08:14:53 25.00 275,000 Buy* 24.00 25.90 68.75k O
21-Sep-21 08:14:38 25.135 96,101 Sell* 25.00 25.90 24.15k O
21-Sep-21 08:14:34 25.00 3,000 Sell* 25.00 25.90 750.00 O
21-Sep-21 08:14:34 25.00 3,000 Sell* 25.00 25.90 750.00 O
21-Sep-21 08:14:28 25.00 50,000 Buy* 24.00 25.90 12.50k O
21-Sep-21 08:14:22 25.00 150,000 Buy* 24.00 25.90 37.50k O
21-Sep-21 08:14:17 25.00 32,168 Buy* 24.00 25.90 8,042 O
21-Sep-21 08:14:13 25.00 50,000 Buy* 24.00 25.90 12.50k O
21-Sep-21 08:14:00 25.00 10,000 Buy* 24.00 25.90 2,500 O
21-Sep-21 08:13:55 25.00 17,056 Buy* 24.00 25.90 4,264 O
21-Sep-21 08:13:54 25.05 25,000 Buy* 24.00 25.90 6,263 O
21-Sep-21 08:13:52 25.00 25,000 Buy* 24.00 25.90 6,250 O
21-Sep-21 08:13:51 25.00 200,000 Buy* 24.00 25.90 50.00k O
21-Sep-21 08:13:48 25.00 29,000 Buy* 24.00 25.90 7,250 O
21-Sep-21 08:13:43 25.00 20,000 Buy* 24.00 25.90 5,000 O
21-Sep-21 08:13:29 25.00 50,000 Buy* 24.00 25.90 12.50k O
21-Sep-21 08:13:28 25.00 53,556 Buy* 24.00 25.90 13.39k O
21-Sep-21 08:13:25 25.00 17,264 Buy* 24.00 25.90 4,316 O
fantastic news! 45% increase in revenue to £246 million, profit after tax increased by 211%!!
Fantastic RNS, MOU with £17 billion mcap giant SSE :)
so a JV is bad news now?? what a muppet lol
still off the radar, LSE isnt working, it should be top of the riser board!
$6 bil worth of gas and the mcap is only £15 mil, watch it go bananas this afternoon
0.28 paid
huge news, difficult to buy
7s?? are you a ******
drop overdone, watch it bounce now
we are heading in the right direction, thats the main thing, you can't expect approval in the morning and then get a massive order by lunch time
Huge news, Artemic is proven effective treating patients with severe covid too!
· ArtemiC™, MGC's proprietary nutraceutical food supplement designed to support the immune system, has received regulatory approval for sale in Germany and has been issued a Certificate of Free Sale, opening the door to the European Union and international markets.
· ArtemiC™ utilises Swiss Pharmacan AG's patented MyCell™ technology which increases the bioavailability of the natural ingredients used in the ArtemiCTM formulation.
· ArtemiCTM successfully underwent a Phase II Clinical Trial in 2020, which demonstrated efficacy in improving and expediting the clinical recovery of patients with mild COVID-19, as detailed in previous Company announcements
· Separately, as part of the registration process for CimetrA™ in India, an observational open label controlled Clinical Trial of its sister product ArtemiCTM, showed that the formulation demonstrated its efficacy in the treatment of patients with severe COVID-19 for the first time
Happy days!
0.67 AUD at the moment which is 3.55p
Fantastic!
CannEpil+, based on CannEpilTM, designed by MGC Pharma to treat Refractory Epilepsy, has been approved for import into the UK by the Medicines and Healthcare products Regulatory Agency via its UK distribution and clinical access partner Elite Pharmaco.
· This is the first time that an epilepsy treatment currently in a Clinical Trial process, and containing THC, has been approved by the authorities in the UK for import.